Research dossier
Clinical research on MSM
7 trials reviewed across 4 indications.
Strongest evidence
Osteoarthritis pain & joint function
Mechanism
MSM is an organic sulfur compound and a metabolite of DMSO. Proposed actions include scavenging reactive oxygen species and dampening NF-κB-driven inflammatory cytokines (IL-1β, TNF-α) in the joint. Sulfur is also a substrate for connective-tissue components, though a direct cartilage-building effect is unproven.
This is MSM's best claim. Across several small RCTs (1.5–6 g/day, 12 weeks) it reduces OA pain and improves function versus placebo, and a 2008 review judged it 'positive but not definitive.' Effect sizes are modest, the trials are short, and the most-cited Debbi 2011 trial actually missed significance on pain — so calibrate expectations to 'modest symptomatic relief.'
Best supported in mild-to-moderate knee OA. It relieves symptoms; it has not been shown to slow cartilage loss or modify disease structurally.
Trials cited
Kim — MSM for knee osteoarthritis pain
positive · RCT
Kim et al., 2006, Osteoarthritis and Cartilagen=5050 knee-OA patients on 6 g/day MSM for 12 weeks had significantly greater improvement in WOMAC pain and physical-function scores than placebo. The most-cited single-ingredient MSM osteoarthritis RCT and the basis for the 6 g/day dosing seen in many products.
Small (n=50), short (12 weeks), and described by the authors as a pilot. WOMAC stiffness and several secondary measures did not separate as clearly. No structural or long-term data.
Debbi — MSM supplementation for knee OA
mixed · RCT
Debbi et al., 2011, BMC Complementary and Alternative Medicinen=4949 knee-OA patients on ~3.4 g/day MSM. WOMAC physical FUNCTION improved significantly versus placebo (p=0.04), but the primary PAIN endpoint did NOT reach significance (p=0.08), nor did stiffness (p=0.08). The authors explicitly noted the improvements were 'small' and of uncertain clinical significance.
Frequently cited online as a clean positive — it isn't. Pain, the outcome most people care about, missed statistical significance. MSM/placebo material was donated by manufacturer Taam Teva (no other involvement); funding was institutional.
Usha — glucosamine, MSM, and combination for knee OA
positive · RCT
Usha & Naidu, 2004, Clinical Drug Investigationn=118Four-arm RCT (n=118): MSM, glucosamine, and their combination all beat placebo on the Lequesne Index and pain (~33% pain reduction with MSM), with the combination outperforming either alone on pain and swelling. Supports both standalone MSM and the common glucosamine+MSM stack.
Single site, 12 weeks, relatively low MSM dose (1.5 g/day vs the 3–6 g/day used elsewhere). The combination benefit is plausible but doesn't isolate MSM's independent contribution cleanly.
Toguchi — OptiMSM for mild knee pain
positive · RCT
Toguchi et al., 2023, Nutrientsn=88Industry-funded88 adults with mild knee pain on 2 g/day OptiMSM for 12 weeks improved on the JKOM total score versus placebo (p=0.046), with gains in morning pain, nocturnal pain, pain while standing, and overall health condition. Extends the signal to a milder, pre-OA population at a lower 2 g dose.
Borderline significance (p=0.046) on a subjective questionnaire. Funded by Chlorella Industry and using OptiMSM (Bergstrom Nutrition) — an industry-tied study despite a no-conflict declaration.
Brien — systematic review of MSM and DMSO for OA
mixed · Systematic review
Brien et al., 2008, Osteoarthritis and Cartilagen=6Reviewed 6 RCTs (MSM and the related compound DMSO). Both MSM trials reported significant pain improvement versus comparator, and four of six studies scored high for quality. But the authors concluded the data is 'positive but not definitive' — MSM is probably superior to placebo for mild-to-moderate knee OA, with lingering questions on optimal dose and treatment duration.
Few trials, short durations, and unresolved dosing. The reviewers stopped short of a firm endorsement — 'no definitive conclusion can currently be drawn.' This is the honest ceiling on the MSM-for-joints claim.
Combination with glucosamine
Mechanism
MSM and glucosamine target different parts of the joint problem — MSM on inflammation/oxidative stress, glucosamine as a cartilage-matrix substrate — giving a rationale for additive symptom relief.
In the one head-to-head four-arm trial, MSM + glucosamine reduced pain and swelling more than either alone over 12 weeks. The popular glucosamine+MSM joint stack has at least one RCT behind the combination, not just marketing.
Single trial supports the combination. It doesn't prove MSM adds a lot on top of glucosamine in everyone — the increment was modest.
Usha — glucosamine, MSM, and combination for knee OA
positive · RCT
Usha & Naidu, 2004, Clinical Drug Investigationn=118Four-arm RCT (n=118): MSM, glucosamine, and their combination all beat placebo on the Lequesne Index and pain (~33% pain reduction with MSM), with the combination outperforming either alone on pain and swelling. Supports both standalone MSM and the common glucosamine+MSM stack.
Single site, 12 weeks, relatively low MSM dose (1.5 g/day vs the 3–6 g/day used elsewhere). The combination benefit is plausible but doesn't isolate MSM's independent contribution cleanly.
Exercise recovery & muscle soreness
Mechanism
The same antioxidant / anti-inflammatory rationale proposed for joints — theoretically blunting exercise-induced oxidative stress and soreness.
One tiny trial (n=22) found 3 g/day OptiMSM did nothing for oxidative-stress or muscle-damage blood markers, but slightly reduced subjective post-race muscle and joint pain (clinically, not statistically, significant). A weak, preliminary recovery signal — not a reason to expect meaningful DOMS reduction.
Preliminary and underpowered. The objective biomarkers were null; only the subjective pain reading hinted at any effect.
Withee — OptiMSM for exercise-induced muscle damage
mixed · RCT
Withee et al., 2017, Journal of the International Society of Sports Nutritionn=22Industry-funded22 runners on 3 g/day OptiMSM. MSM did NOT reduce oxidative-stress or muscle-damage (creatine kinase) markers, but it attenuated post-race muscle and joint pain at a clinically — though not statistically — significant level. A weak, suggestive recovery signal, not a confirmed one.
Tiny (n=22) and underpowered. The biomarker endpoints were flatly null; only the subjective pain reading hinted at benefit. OptiMSM/industry-supported. Treat exercise-recovery as preliminary.
Seasonal allergic rhinitis
Mechanism
Hypothesized anti-inflammatory effect on the nasal mucosa — but the trial that suggested benefit found NO change in histamine or IgE, leaving the mechanism unexplained.
A single open-label trial (n=50, no placebo) found 2,600 mg/day reduced seasonal-allergy respiratory symptoms over 30 days. With no control group and no change in allergy biomarkers, this is a hypothesis-generating signal, not evidence MSM treats allergies.
No placebo control means expectancy and seasonal change can't be ruled out. Don't substitute MSM for proven allergy treatment.
Barrager — MSM for seasonal allergic rhinitis
positive · Pilot
Barrager et al., 2002, Journal of Alternative and Complementary Medicinen=50Industry-funded50 allergy sufferers on 2,600 mg/day OptiMSM reported reduced respiratory symptoms by day 7, building to day 14 and holding through day 30, plus improved energy. Notably, plasma histamine and IgE did NOT change — so the mechanism behind the symptom relief is unexplained.
Open-label, single-arm, NO placebo control — the symptom improvement could be expectancy, seasonal variation, or regression to the mean. The unchanged histamine/IgE undercuts a clear mechanism. Preliminary at best.
2 forms of MSM compared
OptiMSM® (Bergstrom Nutrition)
Distillation-purified MSM (OptiMSM)
Highly water-soluble and well absorbed; distillation purification removes contaminants
Best forJoint pain and function — the most clinically studied MSM formOptiMSM is the only MSM purified by distillation (vs crystallization) and is the branded material used in most of the modern trials (Withee 2017, Barrager 2002, Toguchi 2023). When a product names OptiMSM you know the source and purity; generic MSM does not guarantee either.
bone1500–6000 mgGeneric / crystalline MSM (methylsulfonylmethane)
Well absorbed; purity and contaminant profile vary by supplier
Best forJoint pain and functionChemically identical to branded MSM, but generic crystalline MSM is typically crystallization-purified and quality control varies between manufacturers. Effective in trials (Kim 2006, Debbi 2011, Usha 2004 all used standard MSM), but with less assurance about purity than a verified distilled source.
bone1500–6000 mg
Are you deficient? Symptoms, risk groups, lab tests
MSM is an organic sulfur compound found in trace amounts in foods (and synthesized industrially), not an essential nutrient — there is no dietary requirement and no 'MSM deficiency.' It is supplemented for its pharmacological anti-inflammatory effect, primarily on joints.
Side effects and drug interactions
Side effects
Mild gastrointestinal upset
Common · More likely at the higher 3–6 g/day doses
The most common complaint — nausea, bloating, diarrhea, or mild abdominal discomfort. Usually transient and dose-related; taking it with food and splitting the dose helps.
Headache
Uncommon
Occasional, mild, and usually self-limiting in the first days of use.
Insomnia or mild fatigue
Uncommon
Some users report sleep disturbance or transient fatigue; reported inconsistently across trials.
Skin itching or rash
Uncommon
Uncommon and mild. MSM was well tolerated across the OA trials, which reported few adverse events and good safety up to 6 g/day.
Drug interactions
Other
blood thinners (warfarin, antiplatelets) — theoreticalNSAIDsNo established clinical interactions. A theoretical additive anti-inflammatory effect with NSAIDs and an unconfirmed bleeding-risk concern with anticoagulants are sometimes raised, but neither is documented in human trials.
No meaningful interactions are established. As a sensible precaution, mention MSM to your prescriber if you take anticoagulants, but the concern is theoretical.
Other critical caveats
- MSM provides symptomatic relief, not disease modification. No trial has shown it slows cartilage loss or changes the structural course of osteoarthritis — judge it on pain and function over 4–12 weeks, not on 'rebuilding the joint.'
- Effect sizes are modest and the trials are small and short (≤12 weeks). The most-cited Debbi 2011 trial actually MISSED statistical significance on its pain endpoint, and a 2008 systematic review called the overall evidence 'positive but not definitive.'
- Several of the supporting trials used the branded OptiMSM material and were funded or supported by parties with a commercial interest. The signal is consistent enough to take seriously, but expect smaller real-world effects than headline claims.
- Exercise-recovery and seasonal-allergy uses rest on tiny or uncontrolled (open-label) trials. Treat them as preliminary, not established.
- MSM is among the better-tolerated joint supplements — mild GI upset is the main side effect, and no meaningful drug interactions are established.
Frequently asked
Does MSM actually help joint pain?
For knee osteoarthritis, modestly and with reasonable consistency. Several small RCTs at 1.5–6 g/day for 12 weeks show reduced pain and improved function versus placebo, alone or stacked with glucosamine, and a 2008 review judged the evidence 'positive but not definitive.' The honest caveats: trials are small and short, effect sizes are modest, the most-cited trial actually missed significance on pain, and several studies are tied to the MSM manufacturer. Think modest relief, not a cure.How much MSM should I take?
Trials used 1.5–6 g/day. Kim 2006 used 6 g/day; Debbi 2011 ~3.4 g/day; the milder-pain Toguchi 2023 trial used 2 g/day; Usha 2004 used 1.5 g/day in a glucosamine combination. A common practical range is 3 g/day, split with meals to reduce GI upset. Give it at least 4–12 weeks before judging it.What's the difference between OptiMSM and regular MSM?
OptiMSM is purified by distillation rather than crystallization, which controls purity and contaminants, and it's the branded material used in most modern MSM trials. Generic crystalline MSM is the same molecule and worked in the older OA trials, but quality control varies by supplier. If purity matters to you, OptiMSM is the verified option.Does MSM rebuild cartilage or just mask pain?
Neither claim is well supported. MSM eases osteoarthritis symptoms — pain and function — in short trials, but no study has shown it slows cartilage loss or modifies the disease structurally. It's best understood as symptomatic anti-inflammatory relief, not a structural repair agent.Is MSM safe?
It's one of the better-tolerated joint supplements. The main side effect is mild GI upset (nausea, bloating, loose stools), most likely at higher doses and helped by taking it with food. It's been used safely up to 6 g/day in 12-week trials, and no meaningful drug interactions are established — though as a precaution, mention it to your prescriber if you take anticoagulants.
References
- 01Examine.com — MSM (Methylsulfonylmethane)
- 02Brien et al. 2008 — Systematic review of MSM and DMSO for osteoarthritis (Osteoarthritis Cartilage)
- 03Kim et al. 2006 — MSM for knee osteoarthritis pain (Osteoarthritis Cartilage)
- 04Debbi et al. 2011 — MSM supplementation for knee OA (BMC Complement Altern Med)
Last reviewed2026-05-24